The associations between spirituality (S), religiosity (R), and spiritual pain (SP) in advanced cancer patients (AdCa). Background: Cetuximab, an epidermal growth factor receptor (EGFR) inhibitor ...

Cetuximab has clearly increased the therapeutic armamentarium for the treatment of patients with mCRC. Studies looking at clinical, biochemical, and molecular markers for increased activity have been ...

Chemoradiotherapy regimens for locoregionally advanced nasopharyngeal carcinoma: A Bayesian network meta-analysis. This is an ASCO Meeting Abstract from the 2014 ASCO Annual Meeting I. This abstract ...

An investigational novel cream containing a BRAF inhibitor appears to ameliorate the acneiform rash associated with epidermal growth factor receptor (EGFR) inhibitors such as cetuximab (Erbitux) and ...

Maintenance therapy with cetuximab (Erbitux) after FOLFIRI (leucovorin, fluorouracil, and irinotecan) plus cetuximab induction therapy led to better outcomes for patients with RAS wild-type metastatic ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved cetuximab in combination with encorafenib for treatment of certain patients with colorectal ...

FRANKFURT, Nov 13 (Reuters) - Merck KGaA said its key drug Erbitux was shown to be particularly effective against lung cancer in patients that developed skin rashes during therapy, potentially ...

Erbitux (cetuximab) is a brand-name drug prescribed for certain types of cancer in adults. Erbitux comes as an intravenous (IV) infusion that’s given by a healthcare professional once per week or ...

FRANKFURT (Reuters) - Merck KGaA said on Wednesday a Phase II trial provided further evidence that its cancer drug Erbitux was particularly effective at fighting bowel tumors whose cells did not ...

Erbitux (cetuximab) is a prescription drug that’s used to treat certain types of cancer. The drug comes as a solution that’s given through a vein by a healthcare professional. It’s usually given once ...